Oncogene, Published online: 12 September 2026; doi:10.1038/s41388-026-03985-5
Development and preclinical evaluation of a decoy DLL4-encoding oncolytic HSV-1 for high-grade glioma
Oncogene, Published online: 12 September 2026; doi:10.1038/s41388-026-03988-2
Circular RNA MCM3 recruits USP49 to stabilize PTBP1 and promote cisplatin resistance in cervical squamous cell carcinoma
Oncogene, Published online: 11 September 2026; doi:10.1038/s41388-026-03986-4
CircRHBDD1(4,5) drives malignant progression of oral squamous cell carcinoma by enhancing DKK1 mRNA stability through facilitating m6A-dependent IGF2BP2 binding
Oncogene, Published online: 11 September 2026; doi:10.1038/s41388-026-03976-6
Tumor-derived CTHRC1 mediates ITGB3-dependent osteoclast differentiation to promote prostate cancer bone metastasis
Oncogene, Published online: 11 September 2026; doi:10.1038/s41388-026-03979-3
Propionyl-CoA catabolism is a metabolic gatekeeper for fatty acid oxidation in pancreatic cancer
Oncogene, Published online: 04 September 2026; doi:10.1038/s41388-026-03966-8
ITGA5 promotes homologous recombination mediated radioresistance in esophageal squamous cell carcinoma by upregulating RAD51AP1 expression
Oncogene, Published online: 04 September 2026; doi:10.1038/s41388-026-03964-w
A step-wise, deterministic and fatal mouse model of myeloid neoplasm with spontaneous acquisition of patient-relevant RTK–RAS mutations
Oncogene, Published online: 03 September 2026; doi:10.1038/s41388-026-03959-7
The RNA-binding protein La/SSB is associated with HNSCC progression and TFAP2C/FSCN1-linked transcriptional regulation
Oncogene, Published online: 01 September 2026; doi:10.1038/s41388-026-03958-8
The GSEC-encoded polypeptide GESP drives colorectal cancer tumorigenesis via NPM1-c-Myc-mediated repression of NDRG1
Oncogene, Published online: 01 September 2026; doi:10.1038/s41388-026-03969-5
Neuromedin U ‘innervation’ reprograms myeloid immunosuppression in neuroendocrine prostate cancer
Oncogene, Published online: 31 August 2026; doi:10.1038/s41388-026-03974-8
Frequently amplified SHANK2 promotes esophageal squamous cell carcinoma progression through the DVL/YAP axis
Oncogene, Published online: 31 August 2026; doi:10.1038/s41388-026-03973-9
POC1A promotes the proliferation, metastasis and stemness of bladder cancer by stabilizing BMI1 via USP7
Oncogene, Published online: 29 August 2026; doi:10.1038/s41388-026-03967-7
DHCR24+ tumor epithelial cells drive cisplatin resistance in bladder cancer by enhancing cholesterol metabolism to activate lipid raft-associated MAPK signaling
Oncogene, Published online: 24 May 2026; doi:10.1038/s41388-026-03826-5
Liver-specific SIRT1 knockout-induced hyperglycemia promotes spontaneous lung adenocarcinomas through HSF1-MDM2
Oncogene, Published online: 23 May 2026; doi:10.1038/s41388-026-03827-4
Signals from the bone marrow B cell niches shape pre-leukemic fate in a murine model of B cell acute lymphoblastic leukemia
Oncogene, Published online: 23 May 2026; doi:10.1038/s41388-026-03825-6
Lactic acid induces dendritic cell pyroptosis through MCT-1 to promote tumor immune evasion
Oncogene, Published online: 22 May 2026; doi:10.1038/s41388-026-03711-1
GPX8+ cancer-associated fibroblast-derived lactate contributes to lenvatinib resistance by facilitating BRPF1 expression through histone H3 lysine 18 lactylation in hepatocellular carcinoma
Oncogene, Published online: 21 May 2026; doi:10.1038/s41388-026-03819-4
circPARPBP promotes cancer stemness and chemoresistance in triple-negative breast cancer through recruiting SRCAP complex to activate CCL20 transcription
Oncogene, Published online: 19 May 2026; doi:10.1038/s41388-026-03823-8
NDRG2 orchestrates circadian clock stability to suppress tumorigenesis and potentiate oxaliplatin response in colorectal cancer
Oncogene, Published online: 14 May 2026; doi:10.1038/s41388-026-03813-w
ESR1 fusion proteins in breast cancer: distinguishing oncogenic drivers from passenger events
Login